Paul Hunter Peckham is a professor of biomedical engineering and orthopedics at the Case Western Reserve University, and holds eight patents related to neural prosthetics. Peckham's research involves developing prostheses to restore function in the upper extremities for paralyzed individuals with spinal cord injury.
Peckham is the oldest son in his family, where his father was a package salesman based in Elmira, New York. [1] He completed a Bachelor of Science degree in mechanical engineering at the Clarkson College of Technology. [2] He later pursued a Master of Science degree, and a doctorate in biomedical engineering at Case Western Reserve University. [1] [2] [3] Peckham was based in a research lab based at the Highland View Hospital, where he was carrying out research in the field of spinal cord injury. [3]
Peckham joined the Case Western Reserve University as a member of the faculty in 1972, and is currently a Donnell professor of Biomedical Engineering and Orthopaedics, where his research involves using functional electrical stimulation to restore function to upper extremities, including hands and arms, in paralyzed individuals with spinal cord injuries. [4]
In 1977, Peckham met Jim Jatich, who had been left without movement in his fingers and a wrist as a result of a diving accident. [1] In collaboration with 25 doctors and researchers, Peckham co-developed multiple iterations of neural prostheses over nine years, which could be implanted, and relied on electrical stimulation to control neuromuscular activation. [1] [5] [6] [7] This neural prosthetic, called Freehand, was further tested with Jatich, who was able to type using an electric typewriter six months after implantation. [1] Peckham later founded NeuroControl Corp. in the 1990s, raising $30 million in funding and receiving two Food & Drug Administration approvals for functional electrical stimulation products for spinal cord patients (including selling Freehand to the public), before the company failed due to insufficient sales. [1] [3]
Peckham holds the position of Distinguished University Professor at Case Western University. [8] He has published over 200 academic papers, with over 15,000 citations, resulting in an h-index and i10-index of 60 and 132 respectively. [9] He is cited as an inventor on eight patents related to neural prosthesis by the United States Patent and Trademark Office. [10] [11]
Throughout the course of his academic career, Peckham has held various administrative roles, including serving as co-director of the MetroHealth Rehabilitation Institute (within the MetroHealth System), the director of the Functional Electrical Stimulation Center, and founding the non-profit Institute for Functional Restoration at Case Western Reserve University. [12] [13] [4] He has served on the scientific advisory board for the IEEE's Transactions on Biomedical Engineering academic journal. [14] In 2004, Peckham spoke about "Paralysis: Natural recovery versus assistive technology?" at the White House/Veteran Affairs Conference dedicated to Emerging Technologies in Support of the New Freedom Initiative: Promoting Opportunities for People with Disabilities. [2]
Peckham has received many awards, including a Paul B. Magnuson Award (2001) from the United States Department of Veterans Affairs, a Lifetime Achievement Award (2015) from the American Spinal Injury Association, a 2020 Lifetime Achievement Award from the North American Neuromodulation Society (NANS), an Annual BCI Research Award (2018), the Frank and Dorothy Humel Hovorka Prize from Case Western Reserve University and was designated as the Pioneer of the Neuroprothesis by the State of Ohio. [4] [15] [16] [8] [17] Peckham was elected as a fellow to the National Academy of Engineering (2002), the American Institute of Medical and Biological Engineering, and the American Spinal Injury Association. [4] [13] [18] [8] He was recognized as an Engineer Of The Year in 2000 by DesignNews. [19]
Peckham has a wife named Sara and two children named Endia(Indy) and Gregory(Greg). Peckham also has three grandchildren named Hayden, Eloise and Beatrice(Bea) [1]
Functional electrical stimulation (FES) is a technique that uses low-energy electrical pulses to artificially generate body movements in individuals who have been paralyzed due to injury to the central nervous system. More specifically, FES can be used to generate muscle contraction in otherwise paralyzed limbs to produce functions such as grasping, walking, bladder voiding and standing. This technology was originally used to develop neuroprostheses that were implemented to permanently substitute impaired functions in individuals with spinal cord injury (SCI), head injury, stroke and other neurological disorders. In other words, a person would use the device each time he or she wanted to generate a desired function. FES is sometimes also referred to as neuromuscular electrical stimulation (NMES).
Neuroprosthetics is a discipline related to neuroscience and biomedical engineering concerned with developing neural prostheses. They are sometimes contrasted with a brain–computer interface, which connects the brain to a computer rather than a device meant to replace missing biological functionality.
Neural engineering is a discipline within biomedical engineering that uses engineering techniques to understand, repair, replace, or enhance neural systems. Neural engineers are uniquely qualified to solve design problems at the interface of living neural tissue and non-living constructs.
Patrick E. Crago is the Allen H. and Constance T.Ford Professor and Chairman of Biomedical Engineering at Case Western Reserve University in Cleveland, Ohio. Crago is a biomedical engineer currently serving as a Principal Investigator at the Cleveland FES Center.
Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons. Neuromodulators typically bind to metabotropic, G-protein coupled receptors (GPCRs) to initiate a second messenger signaling cascade that induces a broad, long-lasting signal. This modulation can last for hundreds of milliseconds to several minutes. Some of the effects of neuromodulators include: alter intrinsic firing activity, increase or decrease voltage-dependent currents, alter synaptic efficacy, increase bursting activity and reconfiguration of synaptic connectivity.
A spinal cord stimulator (SCS) or dorsal column stimulator (DCS) is a type of implantable neuromodulation device that is used to send electrical signals to select areas of the spinal cord for the treatment of certain pain conditions. SCS is a consideration for people who have a pain condition that has not responded to more conservative therapy.
Sacral nerve stimulation, also termed sacral neuromodulation, is a type of medical electrical stimulation therapy.
The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation – the alteration of nerve activity through the delivery of electromagnetic stimulation or chemical agents to targeted sites of the body. Neuromodulation is a burgeoning field – analysts forecast a double-digit annual growth rate through 2026. Founded in 1989 and based in San Francisco, CA, the INS educates and promotes the field through meetings, its bimonthly, peer-reviewed journal Neuromodulation: Technology at the Neural Interface and chapter websites.
Neurostimulation is the purposeful modulation of the nervous system's activity using invasive or non-invasive means. Neurostimulation usually refers to the electromagnetic approaches to neuromodulation.
Restorative neurology is a branch of neurology dedicated to improving functions of the impaired nervous system through selective structural or functional modification of abnormal neurocontrol according to underlying mechanisms and clinically unrecognized residual functions. When impaired, the body naturally reconstructs new neurological pathways and redirects activity. The field of restorative neurology works to accentuate these new pathways and primarily focuses on the theory of the plasticity of an impaired nervous system. Its main goal is to take a broken down and disordered nervous system and return it to a state of normal function. Certain treatment strategies are used to augment instead of fully replace any performance of surviving and also improving the potential of motor neuron functions. This rehabilitation of motor neurons allows patients a therapeutic approach to recovery opposed to physical structural reconstruction. It is applied in a wide range of disorders of the nervous system, including upper motor neuron dysfunctions like spinal cord injury, cerebral palsy, multiple sclerosis and acquired brain injury including stroke, and neuromuscular diseases as well as for control of pain and spasticity. Instead of applying a reconstructive neurobiological approach, i.e. structural modifications, restorative neurology relies on improving residual function. While subspecialties like neurosurgery and pharmacology exist and are useful in diagnosing and treating conditions of the nervous system, restorative neurology takes a pathophysiological approach. Instead of heavily relying on neurochemistry or perhaps an anatomical discipline, restorative neurology encompasses many fields and blends them together.
Neuromodulation is "the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body". It is carried out to normalize – or modulate – nervous tissue function. Neuromodulation is an evolving therapy that can involve a range of electromagnetic stimuli such as a magnetic field (rTMS), an electric current, or a drug instilled directly in the subdural space. Emerging applications involve targeted introduction of genes or gene regulators and light (optogenetics), and by 2014, these had been at minimum demonstrated in mammalian models, or first-in-human data had been acquired. The most clinical experience has been with electrical stimulation.
A peripheral nerve interface is the bridge between the peripheral nervous system and a computer interface which serves as a bi‐directional information transducer recording and sending signals between the human body and a machine processor. Interfaces to the nervous system usually take the form of electrodes for stimulation and recording, though chemical stimulation and sensing are possible. Research in this area is focused on developing peripheral nerve interfaces for the restoration of function following disease or injury to minimize associated losses. Peripheral nerve interfaces also enable electrical stimulation and recording of the peripheral nervous system to study the form and function of the peripheral nervous system. For example, recent animal studies have demonstrated high accuracy in tracking physiological meaningful measures, like joint angle. Many researchers also focus in the area of neuroprosthesis, linking the human nervous system to bionics in order to mimic natural sensorimotor control and function. Successful implantation of peripheral nerve interfaces depend on a number of factors which include appropriate indication, perioperative testing, differentiated planning, and functional training. Typically microelectrode devices are implanted adjacent to, around or within the nerve trunk to establish contact with the peripheral nervous system. Different approaches may be used depending on the type of signal desired and attainable.
The Shannon criteria constitute an empirical rule in neural engineering that is used for evaluation of possibility of damage from electrical stimulation to nervous tissue.
The Case Western Reserve University Department of Biomedical Engineering launched in 1968 as one of the first Biomedical Engineering programs in the world. Formally incorporated in both the School of Engineering and School of Medicine, the department provides full research and education programs and is consistently top-ranked for graduate and undergraduate studies, according to U.S. News & World Report.
Spinal cord injury research seeks new ways to cure or treat spinal cord injury in order to lessen the debilitating effects of the injury in the short or long term. There is no cure for SCI, and current treatments are mostly focused on spinal cord injury rehabilitation and management of the secondary effects of the condition. Two major areas of research include neuroprotection, ways to prevent damage to cells caused by biological processes that take place in the body after the insult, and neuroregeneration, regrowing or replacing damaged neural circuits.
Stentrode is a small stent-mounted electrode array permanently implanted into a blood vessel in the brain, without the need for open brain surgery. It is in clinical trials as a brain–computer interface (BCI) for people with paralyzed or missing limbs, who will use their neural signals or thoughts to control external devices, which currently include computer operating systems. The device may ultimately be used to control powered exoskeletons, robotic prosthesis, computers or other devices.
Milos R. Popovic is a scientist specializing in Functional Electrical Stimulation (FES) and neurorehabilitation. As of 2018, he is Director of the KITE Research Institute at UHN Toronto Rehabilitation Institute (TRI), and a Professor with the Institute of Biomaterials and Biomedical Engineering at the University of Toronto.
Neural dust is a term used to refer to millimeter-sized devices operated as wirelessly powered nerve sensors; it is a type of brain–computer interface. The sensors may be used to study, monitor, or control the nerves and muscles and to remotely monitor neural activity. In practice, a medical treatment could introduce thousands of neural dust devices into human brains. The term is derived from "smart dust", as the sensors used as neural dust may also be defined by this concept.
Karen Anne Moxon, Professor of Bioengineering at University of California, Davis. is a specialist in brain-machine-interfaces. She is best known for her neural engineering work, and is responsible for the first demonstration of a closed-loop, real-time brain machine interface system in rodent subjects, which was later translated to both non-human primates and humans with neurological disorders. She currently runs the Moxon Neurorobotics Laboratory at the University of California, Davis.
Chet T. Moritz is an American neural engineer, neuroscientist, physiologist, and academic researcher. He is an Associate Professor of Electrical and Computer Engineering, and holds joint appointments in the School of Medicine departments of Rehabilitation Medicine, and Physiology & Biophysics at the University of Washington.